
Novavax NVAX
€ 8.77
1.33%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Novavax ROE 2011-2026 | NVAX
ROE Jährlich Novavax
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -344.65 | 30.06 | 76.03 | 103.76 | 495.84 | -66.69 | 71.33 | 110.01 | 180.64 | 5048.07 | -53.62 | -36.12 | -25.58 | -35.53 | -35.96 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5048.07 | -344.65 | 367.84 |
ROE Vierteljährlich Novavax
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -250.36 | -356.49 | -677.18 | 2.44 | 21.72 | 17.96 | 47.89 | 44.41 | 74.2 | 84.71 | 214.83 | 463.61 | 393.72 | 294.03 | 124.35 | -138.58 | -170.04 | -131.61 | -87.14 | -38.38 | -21.26 | 19.89 | 43.98 | 71.33 | 83.6 | 100.44 | 105.64 | 110.01 | 130.61 | 147.92 | 165.13 | 180.64 | 1160.4 | 2311.18 | 3698.25 | 5048.07 | 3991.41 | 2785.47 | 1347.64 | -53.62 | -40.43 | -37.71 | -38.44 | -36.12 | -29.3 | -28.24 | -26.67 | -25.58 | -28.68 | -30.14 | -31.3 | -35.53 | -32.4 | -29.37 | -31.26 | -35.96 | -5.96 | -9.27 | -13.84 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5048.07 | -677.18 | 352.79 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Xeris Pharmaceuticals
XERS
|
4.05 | $ 6.03 | -1.55 % | $ 885 M | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
UroGen Pharma Ltd.
URGN
|
145.53 | $ 19.2 | -11.52 % | $ 554 M | ||
|
uniQure N.V.
QURE
|
-100.04 | $ 10.89 | -30.36 % | $ 530 M | ||
|
GT Biopharma
GTBP
|
-489.96 | $ 0.47 | -2.41 % | $ 892 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
AbCellera Biologics
ABCL
|
-15.14 | $ 3.74 | 3.6 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | ||
|
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
160.57 | $ 3.36 | 0.86 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Agios Pharmaceuticals
AGIO
|
-34.6 | $ 29.16 | -3.54 % | $ 1.69 B | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Завод ДИОД
DIOD
|
3.1 | - | - | - | ||
|
Фармсинтез
LIFE
|
-51.75 | - | - | - | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
-466.34 | $ 2.19 | -9.77 % | $ 226 M | ||
|
Entera Bio Ltd.
ENTX
|
-149.78 | $ 1.38 | -0.72 % | $ 63.3 M | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
-115.61 | - | 10.36 % | $ 9.8 M | ||
|
Altimmune
ALT
|
-76.97 | $ 4.21 | -2.32 % | $ 299 M | ||
|
Teligent, Inc.
TLGT
|
473.41 | - | -13.85 % | $ 16.1 M | ||
|
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | ||
|
Evogene Ltd.
EVGN
|
-41.09 | $ 0.84 | -4.24 % | $ 27.9 M | ||
|
Viela Bio, Inc.
VIE
|
-40.09 | - | - | $ 2.91 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Amarin Corporation plc
AMRN
|
-8.45 | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
AbbVie
ABBV
|
-55.54 | $ 233.57 | 0.64 % | $ 413 B | ||
|
Blueprint Medicines Corporation
BPMC
|
-22.46 | - | - | $ 8.14 B | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
AIM ImmunoTech
AIM
|
-50.55 | $ 0.8 | -11.6 % | $ 38.5 M | ||
|
Aptorum Group Limited
APM
|
-20.19 | $ 0.83 | 5.37 % | $ 4.53 M | ||
|
Apellis Pharmaceuticals
APLS
|
6.05 | $ 20.67 | -1.38 % | $ 2.61 B |